Depressed veterans with heart disease face financial barriers to care

American Heart Association Meeting Report APS.02 - Poster Session II, Presentation 138

April 03, 2017 Categories: Heart News, Scientific Conferences & Meetings

Study Highlights:

  • Veterans living with heart disease and depression were more likely to report problems affording medical visits and prescription drugs and were more likely to delay seeking medical care.
  • More than 20 percent of veterans with cardiovascular disease also suffered from depression in 2013.

Embargoed until 12:30 p.m. ET, Monday, April 3, 2017

ARLINGTON, Virginia April 3, 2017 — Veterans with heart disease who are also depressed are more likely than those without depression to have trouble paying for medications and medical visits and often report delays in seeking medical care, according to research presented at the American Heart Association’s Quality of Care and Outcomes Research 2017 Scientific Sessions.

Data from the Centers for Disease Control and Prevention’s 2013 Behavioral Risk Factor Surveillance System survey was used to study 13,126 veterans who reported being told that they had a heart attack, stroke, or angina or coronary heart disease by a health professional.

Of those studied, 22 percent reported having been diagnosed with depression. Veteran heart patients with depression were more likely to be older and non-white, and were less likely to be employed, own a home, and had lower annual income.

They had higher rate of high blood pressure, elevated cholesterol, chronic obstructive pulmonary disease (a lung disease that causes breathing difficulty), chronic kidney disease, asthma, smoking, obesity and lack of physical inactivity.

Compared to veteran heart patients without depression, those with depression were about:

  • twice as likely to report difficulty affording medical care

  • twice as likely to report delays in seeking medical care; and

  • 45 percent more likely to report difficulty affording prescription drugs.

    Data about the veteran participants in this study came from the participants’ own responses, rather than from medical records. The survey did not discern whether the veterans received care at Department of Veterans Affairs (VA) facilities or other non-VA facilities.

    “All health care providers who treat veterans with depression should routinely ask their patients about any difficulty with being able to pay for medical care or medications,” said the study’s senior author, Puja Parikh, M.D., M.P.H., an interventional cardiologist and assistant professor at Stony Brook School of Medicine and Director of Invasive Cardiology at the Northport Veterans Affairs Medical Center. “In some cases, less expensive medications can be considered and 90-day supply of drugs can be prescribed instead of a 30-day supply which can reduce costs. We can also recommend working with a social worker to obtain vouchers or coupons from pharmaceutical companies to get further financial assistance with medication costs.”

    Healthcare providers also should screen veterans for depression and monitor them for electrocardiogram abnormalities if they are taking anti-depressant medications, because certain psychiatric drugs can predispose some patients to develop arrhythmias. They should also counsel patients on how to take their cardiac medications, she said. Because depressed veteran heart patients are likely to have multiple chronic medical illnesses, they should be followed by a primary care doctor, psychiatrist, and cardiologist.

    “Further, VA-based research could shed more light on how mental illness affects heart disease care for veterans,” Parikh said. Also, future national surveys could include other mental health diagnoses that impact veterans, such as post-traumatic stress disorder (PTSD), she said.

Co-authors are Pallavi Srivastava, M.B.B.S., M.P.H.; Matthew Lacey, B.S.; Javed Butler, M.D., M.P.H.; and A. Laurie Shroyer, Ph.D., M.S.H.A. Author disclosures are on the manuscript.

Additional Resources:

###

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance are available at http://www.heart.org/corporatefunding.

For media inquiries about this news release and AHA spokesperson perspective:

Darcy Spitz: (212) 878-5940; darcy.spitz@heart.org

Carrie Thacker: (214) 706-1665; carrie.thacker@heart.org

For public inquiries:

(800) AHA-USA1 (242-8721)

heart.org and strokeassociation.org

Life is why, science is how . . . we help people live longer, healthier lives